Hero Image
1 November 2021 - 12 December 2021
Berlin, Germany
Matchmaking Virchow 2.0 – Berlin Brandenburg innovation cluster

Program

For more information about the kick-off event on Sep, 27 2021 please see here: MDC event report.


8:30

(Onsite)

Registration and coffee

9:00

(Hybrid)

Welcome and opening remarks

9:10

(Hybrid)


Virchow 2.0 vision: cell-based medicine in Berlin

Nikolaus Rajewsky, director BIMSB at MDC

Angelika Eggert, director Department of Pedriatric Oncology & Hematology at Charité

9:30- 10:10

(Hybrid)

The Clusters4Future initiative

Oliver Pieper, BMBF

Marta Fernandes, Projektträger Jülich

10:10- 10:30

(Hybrid)

Virchow 2.0 conception phase

Marie Vidal, MDC

Thomas Gazlig, Charité BIH Innovation

10:30-11:00

Coffee break

11:00-12:00

(Hybrid)


Innovative single cell technologies

Nikolaus Rajewsky, MDC, Charité

Organoids and Biological Design 2.0

Sarah Hedtrich, BIH/Charité & Jakob Meztger, MDC

Explainable AI-based imaging and omics analysis from histology to single-cells

Frederick Klauschen, LMU Munich, BIFOLD, Charité

Single-cell based identification of new immunotherapy targets

Birgit Sawitzki, BIH/Charité

Development of new cellular therapies guided by cell-based medicine

Annette Künkele, BIH/Charité

12:00-13:00

(Hybrid)

Partner pitches 

(1-2 min flash presentations)

13:00-14:30

Lunch and networking session incl. 1:1 meetings

14:30- 15:30

(Hybrid)


Cell-based medicine: innovation engine for our future?

Peter Albiez, Cluster Speaker HealthCapital Berlin-Brandenburg

Frederick Klauschen, LMU Munich, Charité/BIH, BIFOLD

Heyo Kroemer, CEO Charité

Ulrike Köhl, Director Fraunhofer Institute for Cell Therapy and Immunology, Speaker Clusters4Future SaxoCell

Frank Laukien, CEO Bruker

Ashley Sanders, Single Cell Group Leader, MDC, BIH, Charité

15:30-15:45

Coffee break

15:45-16:45

(Onsite)


5 parallel breakout sessions on

  • Innovative single-cell technologies
  • Predictive personalized disease models
  • Precise molecular and cellular diagnostics
  • New drugs targets and cellular therapies
  • AI-supported clinical decision systems

16:45-17:15

(Hybrid)

Main outcome of each breakout session

17:15-17:45

(Hybrid)

Other aspects of the cluster

Marie Vidal, MDC, 

Tim Conrad, Zuse Institute Berlin, BIFOLD

17:45-18:00

(Hybrid)

Conclusion and next steps, closing remarks

Kai Bindseil, Clustermanager Cluster HealthCapital Berlin Brandenburg &  Head of Division Healthcare/lndustry/Infrastructure at Berlin Partner für Wirtschaft und Technologie

Nikolaus Rajewsky, director BIMSB at MDC

Angelika Eggert, director Department of Pedriatric Oncology & Hematology at Charité

18:00- 20:00

(Onsite)

Networking reception



Registration
Closed since 12 December 2021
Location virtual long term matchmaking
Organised by
Participants
Germany 274
Netherlands 2
Czech Republic 1
United States 1
Switzerland 1
Israel 1
Belgium 1
Pakistan 1
Türkiye 1
India 1
Bulgaria 1
Total 285
Participants
University 125
R&D Institution 73
Company 53
Other 25
Authority/Government 7
Association/Agency 2
Total 285